APPLIED ENERGETICS INC

Rule 10b5-1 Trading Arrangements

During the year ended December 31, 2023, certain of our officers and directors adopted Rule 10b5-1 trading arrangements as follows:

On June 12, 2023, Bradford T. Adamczyk, Executive Chairman, adopted a written plan intended to satisfy the affirmative defense of Rule 10b5-1(c) that took effect on September 15, 2023, and is designed to be in effect until July 15, 2024, with respect to the sale of up to 1,400,000 shares of the company’s common stock all of which underlie stock options held by Mr. Adamczyk. Through March 21, 2024, Mr. Adamczyk has sold 70,000 shares under the plan, consisting of 0.9% of shares he beneficially owns.

On June 12, 2023, Adamczyk Family 2021 LLC (the “Adamczyk LLC”), an entity controlled by Bradford T. Adamczyk, the company’s Executive Chairman, adopted a written plan intended to satisfy the affirmative defense of Rule 10b5-1(c) that took effect on September 15, 2023, and is designed to be in effect until July 15, 2024 with respect to the sale of up to 800,000 shares of the company’s common stock all of which underlie stock options earned by Mr. Adamczyk for services to the company and held by the Adamczyk LLC. No shares have been sold under this plan as of March 21, 2024.

On June 15, 2023, Gregory J. Quarles, President and Chief Executive Officer, adopted a written plan intended to satisfy the affirmative defense of Rule 10b5-1(c) that took effect on September 21, 2023, and is designed to be in effect until July 15, 2024 with respect to the sale of up to 1,300,000 shares of the company’s common stock all of which underlie stock options held by Dr. Quarles. Through March 21, 2024, Mr. Quarles has sold 50,000 shares under the plan, consisting of 0.7% of shares he beneficially owns.

On June 14, 2023, Mary P. O’Hara, General Counsel, Chief Legal Officer, and Secretary adopted a written plan intended to satisfy the affirmative defense of Rule 10b5-1(c) that took effect on September 21, 2023, and is designed to be in effect until July 15, 2024 with respect to the sale of up to 550,000 shares of the company’s common stock all of which underlie stock options held by Ms. O’Hara. No shares have been sold under this plan as of March 21, 2024.

On June 15, 2023, Stephen W. McCahon, Chief Science Officer, adopted a written plan intended to satisfy the affirmative defense of Rule 10b5-1(c) that took effect on September 15, 2023, and is designed to be in effect until March 14, 2024 with respect to the sale of up to 2,100,000 shares of the company’s common stock held by Dr. McCahon. The plan expired in accordance with its terms on March 14, 2024. No shares were sold under this plan.